362 related articles for article (PubMed ID: 24355456)
1. Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition.
Binderup ML; Bisgaard ML; Harbud V; Møller HU; Gimsing S; Friis-Hansen L; Hansen Tv; Bagi P; Knigge U; Kosteljanetz M; Bøgeskov L; Thomsen C; Gerdes AM; Ousager LB; Sunde L;
Dan Med J; 2013 Dec; 60(12):B4763. PubMed ID: 24355456
[TBL] [Abstract][Full Text] [Related]
2. Von Hippel-Lindau syndrome. A pleomorphic condition.
Friedrich CA
Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
[TBL] [Abstract][Full Text] [Related]
3. [Does hemangioblastoma exist outside von Hippel-Lindau disease?].
Richard S; Beigelman C; Gerber S; Van Effenterre R; Gaudric A; Sahel M; Binaghi M; De Kersaint-Gilly A; Houtteville JP; Brunon JP
Neurochirurgie; 1994; 40(3):145-54. PubMed ID: 7723921
[TBL] [Abstract][Full Text] [Related]
4. Surveillance in von Hippel-Lindau disease (vHL).
Poulsen ML; Budtz-Jørgensen E; Bisgaard ML
Clin Genet; 2010 Jan; 77(1):49-59. PubMed ID: 19863552
[TBL] [Abstract][Full Text] [Related]
5. von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance.
Louise M Binderup M; Smerdel M; Borgwadt L; Beck Nielsen SS; Madsen MG; Møller HU; Kiilgaard JF; Friis-Hansen L; Harbud V; Cortnum S; Owen H; Gimsing S; Friis Juhl HA; Munthe S; Geilswijk M; Rasmussen ÅK; Møldrup U; Graumann O; Donskov F; Grønbæk H; Stausbøl-Grøn B; Schaffalitzky de Muckadell O; Knigge U; Dam G; Wadt KA; Bøgeskov L; Bagi P; Lund L; Stochholm K; Ousager LB; Sunde L
Eur J Med Genet; 2022 Aug; 65(8):104538. PubMed ID: 35709961
[TBL] [Abstract][Full Text] [Related]
6. [Von Hippel-Lindau disease: protocols for diagnosis and periodical clinical monitoring. National Von Hippel-Lindau Disease Working Group].
Hes FJ; van der Luijt RB
Ned Tijdschr Geneeskd; 2000 Mar; 144(11):505-9. PubMed ID: 10735135
[TBL] [Abstract][Full Text] [Related]
7. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
[TBL] [Abstract][Full Text] [Related]
8. [Familial and genetic study in a large Chinese kindred with von Hippel-Lindau disease and gene mutation analysis].
Zhang J; Huang YR; Wang JD; Fan XD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):5-9. PubMed ID: 14767899
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the Danish national clinical guidelines for von Hippel-Lindau (VHL).
Bertelsen M; Kosteljanetz M
Acta Neurochir (Wien); 2011 Jan; 153(1):35-41; discussion 41. PubMed ID: 20865287
[TBL] [Abstract][Full Text] [Related]
10. von Hippel-Lindau disease: Diagnosis and factors influencing disease outcome.
Binderup MLM
Dan Med J; 2018 Mar; 65(3):. PubMed ID: 29510814
[TBL] [Abstract][Full Text] [Related]
11. [Pheochromocytoma, first manifestation of Von Hippel-Lindau disease: a possibility to be considered].
Richard S; Resche F; Vermesse B; Fendler JP; Francillard M; Laroche F; Luton JP; Méry JP; Proye C; Redondo A
Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1153-6. PubMed ID: 1482250
[TBL] [Abstract][Full Text] [Related]
12. [Hippel-Lindau disease].
Krzystolik K; Cybulski C; Lubiński J
Neurol Neurochir Pol; 1998; 32(5):1119-33. PubMed ID: 10463227
[TBL] [Abstract][Full Text] [Related]
13. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
[TBL] [Abstract][Full Text] [Related]
14. von Hippel-Lindau disease: genetic, clinical, and imaging features.
Choyke PL; Glenn GM; Walther MM; Patronas NJ; Linehan WM; Zbar B
Radiology; 1995 Mar; 194(3):629-42. PubMed ID: 7862955
[TBL] [Abstract][Full Text] [Related]
15. von Hippel-Lindau disease: surveillance strategy for endolymphatic sac tumors.
Poulsen ML; Gimsing S; Kosteljanetz M; Møller HU; Brandt CA; Thomsen C; Bisgaard ML
Genet Med; 2011 Dec; 13(12):1032-41. PubMed ID: 21912262
[TBL] [Abstract][Full Text] [Related]
16. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.
Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M
J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651
[TBL] [Abstract][Full Text] [Related]
17. Manifestations of Von Hippel Lindau syndrome: a retrospective national review.
O' Brien FJ; Danapal M; Jairam S; Lalani AK; Cunningham J; Morrin M; McNally S; Donovan MG; Little D; Tuthill A; Conlon PJ
QJM; 2014 Apr; 107(4):291-6. PubMed ID: 24352051
[TBL] [Abstract][Full Text] [Related]
18. Calculating optimal surveillance for detection of von Hippel-Lindau-related manifestations.
Kruizinga RC; Sluiter WJ; de Vries EG; Zonnenberg BA; Lips CJ; van der Horst-Schrivers AN; Walenkamp AM; Links TP
Endocr Relat Cancer; 2014 Feb; 21(1):63-71. PubMed ID: 24132471
[TBL] [Abstract][Full Text] [Related]
19. Endolymphatic sac tumors in von Hippel-Lindau disease.
Choo D; Shotland L; Mastroianni M; Glenn G; van Waes C; Linehan WM; Oldfield EH
J Neurosurg; 2004 Mar; 100(3):480-7. PubMed ID: 15035284
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
